Gaspar, R.2015-12-302015-12-302009JOURNAL OF PHARMACY AND PHARMACOLOGY. - Vol. 61, Suppl. Suppl. 1 (2009), p. 2060022-3573http://hdl.handle.net/10451/21507application/pdfengPharmacology & PharmacyThe regulatory landscapeimplications for design and development of nanomedicinesjournal article